New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Boston Scientific Corporation (NYSE:BSX), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT)
Boston Scientific Corporation (NYSE:BSX) declined -0.22%, trading on 14.00 million shares, to end the trade at $13.53. The stock changed hands in a range of $13.30 to $13.67, bringing its market capitalization to about $18.07 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $7.07 and was moved to the maximum level of $14.08. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology.
Has BSX Found The Bottom and Ready To Move Up? Find Out Here
AbbVie Inc (NYSE:ABBV) added 1.90%, to complete the trading session at $49.23, with a total volume of 12.89 million shares. The stock, on average, trades on a volume of 6.90 million shares. It floated in a range of $49.07 to $50.55 during the last trading session. Its market capitalization now moved to about $78.17 billion. In the past 52 weeks, the share price has not declined below $35.01and above $54.78. AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products.
What was the Moving Force behind ABBV on Bullish Run? Read This Research Report
Johnson & Johnson (NYSE:JNJ) recorded a fall of -1.15% and was in a range of $88.15-$89.34 before closing at $88.47. The stock completed the day with a total volume of 12.20 million shares, versus an average volume of 8.14 million shares. The share price hit its 52-week low of $73.56 and $95.99 was the best price. Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world.
Has JNJ Found The Bottom And Ready To Gain Momentum? Find Out Here
Abbott Laboratories (NYSE:ABT) added 0.36% yesterday, bringing its market capitalization around $56.68 billion. The share price, after opening at $36.03, made a high of $36.89 and hovered above $35.97 to end the day at $36.66. The total number of shares that changed hands during the session was 10.85 million shares, as compared to average trading volume of 7.15 million shares. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals.
For How Long ABT will fight for Profitability? Read This Trend Analysis report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)